Skip to content
Victoria Aesthetics Wellness Centre

METABOLIC LONGEVITY & CHRONIC DISEASE PREVENTION

Protect Your Metabolic Future

Support your metabolic healthbefore problems start.

Seychelles' premier low-dose metabolic therapy, designed to maintain your ideal weight, optimise cardiovascular health and extend your healthspan — even if you are not obese.

  • Advanced Clinical Protocol
  • Physician-supervised
  • In-clinic or secure video

Protocols from SCR 5,850 / month

Active adult in sustained metabolic health at Victoria Aesthetics, Seychelles

AT A GLANCE

  • 01

    STATUS

    Advanced Clinical Protocol

    Strict medical supervision

  • 02

    PURPOSE

    Maintenance & Prevention

    Not a rapid weight loss protocol

  • 03

    FROM

    SCR 5,850 / month

    Approximately SCR 195 per day

  • 04

    COMMITMENT

    6 Months Minimum

    For measurable metabolic benefit

Patient in sustained metabolic health after low-dose therapy

THE PROTOCOL

What Is Metabolic Microdosing™?

A precision-engineered, low-dose metabolic maintenance programme using dual-receptor agonists at micro-doses, calibrated to preserve metabolic health, prevent age-related weight regain and reduce cardiovascular risk — without the intensive weight loss focus of our primary programme.

Think of metabolic health as a garden. The intensive weight loss programme is like clearing an overgrown, neglected garden. This protocol is the ongoing maintenance that keeps it thriving: preventing weeds, keeping the soil fertile and protecting against storms.

This is metabolic insurance for your long-term health. It is not a weight loss treatment, but a biological shield against metabolic decline.

THE SCIENCE, EXPLAINED SIMPLY

Why Low-Dose Maintenance Matters.

Metabolic syndrome, insulin resistance and cardiovascular disease develop silently over decades. The point of this protocol is to act before the damage is done.

Metabolic and cardiovascular assessment at Victoria Aesthetics
  • PREVENTION OVER REACTION

    Metabolic syndrome, insulin resistance and cardiovascular disease develop silently over decades. Low-dose therapy intervenes early, before damage becomes irreversible.

  • CARDIOVASCULAR PROTECTION

    Cardiovascular outcome trials of GLP-1 receptor agonists have shown reductions in major adverse cardiovascular events of 20–26%, independent of weight loss (Marso et al., 2016; Husain et al., 2019).

  • INFLAMMATION REDUCTION

    Chronic low-grade inflammation underlies much of ageing and disease. Therapy has been reported to reduce systemic inflammatory markers such as CRP and IL-6, even at low doses (Jurgens et al., 2021).

  • METABOLIC FLEXIBILITY

    Maintains your body’s ability to switch efficiently between burning carbohydrate and fat, preventing the metabolic rigidity that leads to weight gain and disease.

A biological shield, not a diet.

WHAT YOU CAN EXPECT

Six Things This Protocol Is For.

Results vary with your biology, baseline metabolic health, adherence and lifestyle. This protocol is designed for maintenance and prevention, not rapid weight loss.

CARDIOVASCULAR PROTECTION

Reduced cardiovascular risk through improved metabolic markers and direct vascular effects.

WEIGHT MAINTENANCE

Prevention of age-related weight gain and visceral fat accumulation.

INFLAMMATION REDUCTION

Lower systemic inflammation markers, protecting against chronic disease.

METABOLIC OPTIMISATION

Improved insulin sensitivity, blood sugar control and lipid profiles, even if you are not diabetic.

SUSTAINED ENERGY

Stable energy levels through the day, without crashes or brain fog.

LONGEVITY SUPPORT

Activation of cellular pathways associated with healthy ageing and disease resistance.

CANDIDACY

Who Is This Protocol For?

Two distinct groups benefit from low-dose maintenance: those who have already reached their goal, and those who want to protect a metabolism that is still healthy.

GROUP 1

Graduates of our weight loss programme.

  • Patients who have successfully completed our Advanced Medical Weight Loss & Metabolic Reset Protocol.
  • Individuals who have reached their target weight or body composition.
  • Those seeking to prevent weight regain and maintain their metabolic gains long term.

GROUP 2

Proactive health optimisers.

  • Adults 35+ with a family history of cardiovascular disease, diabetes or metabolic syndrome.
  • Individuals with elevated visceral fat despite a healthy BMI.
  • Adults with a normal-high BMI (25–29.9) or early metabolic markers such as insulin resistance, pre-diabetes or inflammation.
  • Those experiencing persistent hunger signals or difficulty with portion control.
  • People seeking gradual, sustainable weight management after diet and exercise alone have fallen short.

YOUR PERSONALISED PROTOCOL

Designed and Supervised by Dr. Eric Licea, MD.

Your protocol is tailored to your metabolic profile, risk factors and longevity goals, with baseline bloodwork and cardiovascular assessment before anything begins.

Low-dose subcutaneous injection prepared at Victoria Aesthetics

CORE PROTOCOL

Low-dose subcutaneous injection.

DOSE
Micro-doses, typically 25–50% of the intensive weight loss dose.
FREQUENCY
Once weekly or every two weeks, depending on individual response.
COMMITMENT
Six months minimum for measurable metabolic benefit and cardiovascular protection.
MONITORING
Monthly check-ins with your physician and dosage adjustments.
BLOODWORK
Baseline and follow-up review of HbA1c, lipid panel, inflammatory markers and cardiovascular risk markers at 3, 6 and 12 months.
SUPPORT
Nutritional counselling and open communication throughout.

All protocols are designed and supervised by Dr. Eric Licea, MD. Baseline metabolic and cardiovascular assessment ensures safety and appropriate outcomes.

YOUR LONGEVITY TIMELINE

What to Expect, and When.

Results vary based on individual biology, baseline metabolic health, adherence to the protocol and lifestyle factors such as nutrition, sleep and physical activity.

  1. WEEKS 1–4

    Metabolic stabilisation, reduced cravings, improved energy stability and initial improvements in inflammatory markers.

  2. WEEKS 5–12

    Noticeable improvements in blood sugar control, lipid profiles and blood pressure. Prevention of seasonal weight gain.

  3. MONTHS 4–6

    Sustained metabolic optimisation, reduced cardiovascular risk markers and enhanced metabolic flexibility.

  4. MONTHS 7–12+

    Long-term disease prevention, maintained body composition and ongoing metabolic resilience.

YOUR INVESTMENT

Transparent Pricing. No Hidden Fees.

All plans include physician supervision, sterile supplies and quarterly progress tracking. Flexible payment plans and a complimentary financial consultation are available.

INITIAL CONSULTATION

SCR 900

100% deductible from your treatment plan.

Comprehensive metabolic and cardiovascular assessment, risk analysis and personalised protocol design.

MONTHLY PROTOCOL

FROM SCR 5,850 / mo

Approximately SCR 195 per day.

Pay-as-you-go flexibility. Includes low-dose medication supply, sterile supplies and monthly physician supervision.

WHY VICTORIA AESTHETICS

Physician-Guided, Science-Backed, Fully Explained.

We do not just offer treatments. We deliver supervised protocols with the assessment, monitoring and honesty that a long-term therapy requires.

  • PHYSICIAN-GUIDED FROM DAY ONE

    Every protocol is designed, prescribed and continuously monitored by Dr. Eric Licea, MD, with comprehensive baseline assessments to ensure safety and results tailored to your biology.

  • PHARMACEUTICAL-GRADE PURITY

    We source exclusively from verified, GMP-certified suppliers. Every batch undergoes rigorous third-party purity and potency testing.

  • HYPER-PERSONALISED PROTOCOLS

    Your plan is built around your risk factors, medical history and longevity goals, with dosage adjusted as your body responds.

  • RADICAL TRANSPARENCY

    We explain the science, realistic timelines, benefits and potential risks in plain language. No jargon, no hidden fees, no pressure.

  • SATISFACTION GUARANTEE

    If you follow our guidelines and feel unsatisfied with your progress after six months, we offer a complimentary consultation to explore protocol adjustments.

PATIENT STORIES

Real Patients. Real Longevity.

Individual results vary. These are personal experiences, not a guarantee of outcome.

“After losing 40 pounds with the intensive program, I was terrified of gaining it back. The low-dose therapy has been my safety net. Two years later, my weight is stable, my bloodwork is perfect, and I feel healthier than I did in my 30s. This is metabolic insurance.”

“I’m not obese — my BMI is 27 — but I have a strong family history of heart disease and diabetes. Dr. Licea explained that low-dose therapy could protect me proactively. My inflammatory markers dropped, my insulin sensitivity improved, and I feel more energetic.”

“I was normal weight but with high visceral fat and pre-diabetic. The intensive programme wasn’t right for me, but the low-dose protocol transformed my metabolic health. My HbA1c normalised and my visceral fat decreased.”

  • +150Patients treated in 2025, associated clinics
  • 4.9/5Average rating
  • 95%Patient satisfaction rate

ENROLMENT CAPACITY

Twelve new patients per quarter.

To maintain our standard of medical care, we limit Metabolic Microdosing™ enrolment to twelve new patients per quarter. This ensures we can dedicate the time required for an in-depth evaluation of your metabolic profile and provide proper ongoing monitoring.

Medical tourists are welcome: consultations are available in clinic in Victoria or by secure video, and discreet delivery can be arranged to your Seychelles accommodation once your protocol has been prescribed.

QUESTIONS

Frequently Asked Questions

Metabolic disease does not require obesity to develop. Insulin resistance, chronic inflammation and cardiovascular risk can occur in individuals with normal weight, particularly those with visceral fat accumulation or genetic predisposition. Cardiovascular outcome trials of GLP-1 receptor agonists have shown reductions in major adverse cardiovascular events of 20–26%, independent of weight loss (Marso et al., 2016; Husain et al., 2019), positioning this class as a preventive tool rather than only a weight loss treatment.

The intensive programme uses higher doses designed for substantial weight loss. Metabolic Microdosing™ uses micro-doses, typically 25–50% of the intensive dose, designed for maintenance, prevention and metabolic optimisation. The goal is metabolic resilience and chronic disease prevention, not rapid weight loss.

Cardiovascular outcome trials have shown cardioprotective benefits beyond weight loss, including reduced blood pressure, improved lipid profiles and anti-inflammatory effects on blood vessels, observed even in patients without diabetes or obesity. Reductions in systemic inflammatory markers and improvements in insulin sensitivity have also been reported at low doses (Jurgens et al., 2021).

Yes, when anchored by lasting lifestyle change. The therapy quiets biological resistance and cravings, giving you the clarity and control to build sustainable habits. The medication supports your behavioural change; it does not replace it.

This class of medication has been used for over a decade in millions of patients worldwide for diabetes management, with a well-characterised long-term safety profile. The most common side effects are mild and transient, such as initial nausea or digestive adjustment, and are minimised at low doses through careful titration.

Via small subcutaneous injections once weekly or every two weeks, self-administered at home after a brief training session. The low-dose regimen is designed for convenience and minimal side effects.

Yes. The protocol is frequently combined with muscle preservation and hormonal optimisation programmes, skin and collagen support, or mitochondrial therapies such as MOTS-c. Your physician will design a safe, synergistic plan.

The protocol is designed for long-term use. If you discontinue, your metabolic risk factors — insulin resistance, inflammation, cardiovascular risk — gradually return to baseline over three to six months. Ongoing use is recommended for sustained protection, in the same way statins are used for lifelong cardiovascular prevention.

While these medications are approved for diabetes and obesity, their use for preventive metabolic optimisation in non-diabetic, non-obese individuals is off-label. We offer the protocol transparently as an Advanced Clinical Protocol under strict medical supervision, with baseline testing and explicit, documented informed consent.

The only way to know is through a comprehensive medical consultation. We review your health history, family history, current metabolic markers and cardiovascular risk profile to determine whether low-dose therapy is a safe and beneficial step for you.

NOT READY YET?

Send me the insights first.

Receive occasional, plainly written updates on advanced metabolic longevity therapies. No pressure, and you can unsubscribe at any time.

WHAT INTERESTS YOU MOST?

READY TO PROTECT YOUR METABOLIC FUTURE?

Insurance you can measure.

Take the first step toward metabolic longevity. Book your confidential consultation with Dr. Eric Licea, MD, and find out whether Metabolic Microdosing™ is right for you.

100% confidential · Physician-led · No obligation · In clinic in Victoria or by secure video

INITIAL CONSULTATION

SCR 900

INCLUDES

  • Comprehensive metabolic & cardiovascular assessment
  • Risk analysis
  • Personalised protocol design
  • 100% deducted from your treatment plan

Medical disclaimer: Educational content only — not medical advice, diagnosis, or a guarantee of individual outcomes. All metabolic and peptide protocols at Victoria Aesthetics are offered under physician supervision, with individual assessment, informed consent and documented follow-up. Metabolic Microdosing™ is an Advanced Clinical Protocol: the use of these medications for preventive metabolic optimisation in non-diabetic, non-obese individuals is off-label.

Privacy and Cookies

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

More information in Cookies polity